The Cardiovascular segment focuses on developing and providing innovative medical devices and therapies for the treatment of cardiovascular diseases. Research and development efforts are centered on creating advanced technologies for coronary interventions, peripheral interventions, and structural heart therapies. This includes drug-eluting stents, balloon catheters, and imaging technologies like intravascular ultrasound. The segment addresses a wide range of conditions, including coronary artery disease, peripheral artery disease, and structural heart defects, aiming to improve patient outcomes through less-invasive procedures and enhanced precision. Market positioning is strong due to a comprehensive product portfolio and a focus on technological advancements. Future opportunities lie in expanding into emerging markets and developing next-generation devices. Regulatory and clinical aspects are critical, with a focus on obtaining FDA approvals and conducting clinical trials to validate the safety and efficacy of new products. Partnerships with healthcare providers and research institutions are essential for innovation and market access.

The MedSurg segment encompasses a broad range of medical devices and technologies used in various surgical and interventional procedures. This segment includes products for endoscopy, urology, and pelvic health. Research and development activities focus on creating advanced diagnostic and therapeutic tools, such as endoscopes, catheters, and minimally invasive surgical instruments. Technologies and methodologies include advanced imaging, robotics, and tissue ablation techniques. The segment addresses a wide array of conditions, including gastrointestinal disorders, urological conditions, and gynecological issues, with the goal of improving patient outcomes through less-invasive procedures and faster recovery times. Market positioning is strong due to a diverse product portfolio and a focus on innovation. Future opportunities include expanding into new therapeutic areas and developing next-generation surgical tools. Regulatory and clinical aspects are crucial, with a focus on obtaining regulatory approvals and conducting clinical trials to demonstrate the safety and efficacy of new products. Partnerships with hospitals and surgical centers are essential for product adoption and market access.

The Rhythm and Neuro segment focuses on developing and providing medical devices and therapies for the treatment of cardiac rhythm disorders and neurological conditions. Research and development efforts are centered on creating advanced technologies for cardiac rhythm management, neuromodulation, and neurovascular interventions. This includes implantable pacemakers, defibrillators, spinal cord stimulators, and deep brain stimulation systems. The segment addresses a wide range of conditions, including arrhythmias, chronic pain, and movement disorders, aiming to improve patient outcomes through advanced therapies and less-invasive procedures. Market positioning is strong due to a focus on innovation and a comprehensive product portfolio. Future opportunities lie in expanding into new therapeutic areas and developing next-generation devices. Regulatory and clinical aspects are critical, with a focus on obtaining FDA approvals and conducting clinical trials to validate the safety and efficacy of new products. Partnerships with neurologists, cardiologists, and research institutions are essential for innovation and market access.